A new study maps the biological influences on thousands of plasma proteins, revealing potential disease biomarkers and drug targets, providing hope for more precise, personalized treatments. Study: ...
Researchers developed a plasma proteomic ageing clock (PAC) – a tool that estimates biological age, reflecting physiological ...
A first-of-its-kind clinical trial clinical trial shows that therapeutic plasma exchange (TPE) combined with intravenous immunoglobin reduced biological age on average by 2.6 years, as measured by ...
The field of electromedicine is witnessing significant advances with the advent of impulse electrical technologies, including nanosecond pulsed bioelectrics ...
Study in Aging Cell shows that therapeutic plasma exchange combined with intravenous immunoglobulin reduced biological age on average by 2.6 years, as measured by multi-omics biomarkers “Unfortunately ...
Learn more about how antiretroviral therapy reduces biological ageing in people with HIV, according to a landmark study presented at ESCMID Global 2026.
First-of-its kind trial shows that therapeutic plasma exchange combined with intravenous immunoglobulin reduced biological age on average by 2.6 years, as measured by multi-omics biomarkers NOVATO, ...
While chronological age is easily measured, it fails to capture the complex biological processes that determine the rate of aging. A new proteomic aging clock may predict biological age, mortality ...
A proteomics study shows that untreated HIV accelerates biological aging by ~10 years, but antiretroviral therapy can reverse ...
Hosted on MSN
Clinical trial demonstrates the impact of therapeutic plasma exchange on biological age
A first-of-its-kind clinical trial shows that therapeutic plasma exchange (TPE) combined with intravenous immunoglobulin reduced biological age on average by 2.6 years, as measured by multi-omic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results